Anika to Issue Fourth Quarter and Year-End 2022 Financial Results on Monday, March 6, 2023GlobeNewsWire • 02/21/23
Anika Announces First Surgeries Performed Using the New RevoMotion™ Reverse Shoulder Arthroplasty System and Commences Limited Market Release in the United StatesGlobeNewsWire • 02/13/23
Is Anika Therapeutics (ANIK) Stock Outpacing Its Medical Peers This Year?Zacks Investment Research • 01/17/23
Anika Therapeutics (ANIK) Reports Q3 Loss, Tops Revenue EstimatesZacks Investment Research • 11/09/22
Anika's Cingal® Successfully Achieves Primary Endpoint in Third Phase III StudyGlobeNewsWire • 11/01/22
Anika to Issue Third Quarter 2022 Financial Results on Tuesday, November 8, 2022GlobeNewsWire • 10/25/22
Anika Announces First Surgeries Performed Using the X-Twist™ Fixation System and Commences Limited Market ReleaseGlobeNewsWire • 09/12/22
Anika Therapeutics Inc. (ANIK) CEO Cheryl Blanchard on Q2 2022 Results - Earnings Call TranscriptSeeking Alpha • 08/06/22
Anika Receives the ACE Award for Cutting-Edge Innovation for Tactoset® Injectable Bone Substitute from the American Orthopedic Society for Sports MedicineGlobeNewsWire • 07/27/22
Anika to Issue Second Quarter 2022 Financial Results on Wednesday, August 3, 2022GlobeNewsWire • 07/12/22
Anika Receives FDA 510(k) Clearance for the X-Twist™ Knotless Fixation System, Expanding its Sports Medicine Soft Tissue PortfolioGlobeNewsWire • 05/20/22
Anika Therapeutics, Inc. (ANIK) CEO Cheryl Blanchard on Q1 2022 Results - Earnings Call TranscriptSeeking Alpha • 05/07/22
Anika to Participate in the 21st Annual Needham Virtual Healthcare ConferenceGlobeNewsWire • 04/04/22
Anika to Showcase its Transformation into a Global Leader in Joint Preservation during the 2022 AAOS Annual MeetingGlobeNewsWire • 03/23/22